U
STJ

UBS’s St Jude Medical STJ Stock Holding History

UBS’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.1M Sell
18,365
-46,047
-71% -$3.01M ﹤0.01% 3487
2014
Q2 		$4.46M Buy
64,412
+10,000
+18% +$648K ﹤0.01% 2071
2014
Q1 		$3.56M Buy
54,412
+49,812
+1,083% +$3.24M ﹤0.01% 2193
2013
Q4 		$285K Sell
4,600
-13,900
-75% -$805K ﹤0.01% 4911
2013
Q3 		$992K Sell
18,500
-10,800
-37% -$556K ﹤0.01% 3344
2013
Q2 		$1.34M Buy
+29,300
New +$1.27M ﹤0.01% 2995

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's STJ Position: Q3 2014 in Review

UBS reduced its St Jude Medical (STJ) stake by 21% in Q3 2014, selling an estimated $4.4M and leaving 259,558 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #1118.

UBS first reported a position in STJ in Q2 2013 and has held it in 6 quarters since. The position peaked at $24.3M in Q1 2014. 563 funds tracked by Wall St. Rank hold STJ as of Q3 2014.

  • UBS held 259,558 shares of St Jude Medical worth $15.6M as of Q3 2014.
  • UBS sold 67,374 St Jude Medical shares in Q3 2014, an estimated $4.4M.
  • St Jude Medical made up 0.01% of UBS's portfolio in Q3 2014, its #1118 holding.
  • UBS first reported a position in St Jude Medical in Q2 2013 and has held it in 6 quarters since.
  • UBS's St Jude Medical position peaked at $24.3M in Q1 2014.
  • 563 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.